ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0236

Maternal Attachment, Anxiety and Depressive Symptoms in Pregnant Women with Rheumatic Diseases

Luis Gerardo Espinosa-Banuelos1, Diana Carolina Rubio Torres2, Maria Corral2, Cassandra Skinner Taylor2, Lorena Perez-Barbosa2, Luz Fernanda Gutierrez Leal2, Abraham Yair Lujano-Negrete3, Jesus Cardenas-de La Garza2 and Dionicio Galarza-Delgado2, 1Faculty of Medicine and University Hospital Dr. Jose Eleuterio Gonzalez, UANL, Monterrey, Mexico, 2Hospital Universitario "Dr Jose E. Gonzalez", Monterrey, Mexico, 3Hospital Universitario Dr. José Eleuterio González, Monterrey, Mexico

Meeting: ACR Convergence 2021

Keywords: Anxiety, depression, pregnancy, psychological status, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Patient Outcomes, Preferences, & Attitudes Poster I: Impact (0225–0240)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Untreated perinatal anxiety symptomatology can be related to symptoms of anxiety and depression during the postpartum. The psychological bond created by the mother between mother and fetus helps to mitigate physical and emotional problems on this stage and in the postpartum. Prenatal maternal attachment acquires special importance because it has been shown that can be a predictor for healthier behavior during pregnancy and better birth outcomes. The aim of this study to correlate the scores between State Trait Anxiety Inventory (STAI), Maternal Antenatal Attachment Scale (MAAS) and Edinburgh Postnatal Depression Scale (EPDS).

Methods: A cross-sectional and descriptive study was conducted from January 2019 to May 2021 at the Pregnancy and Rheumatic Diseases Clinic from the University Hospital “Dr. Jose E. Gonzalez” in Monterrey, Mexico. Pregnant women with ARDs were invited to participate. The STAI is a questionnaire used in clinical settings to diagnose anxiety and to distinguish it from depressive syndromes. It has 20 items for assessing trait anxiety and 20 for state anxiety. All items are rated on a 4-point scale. Higher scores indicate greater anxiety. The MAAS is a 19-item self-report questionnaire which calculates a total attachment score and two subscale scores; one score estimating the quality of the affective attachment and the other that estimates the intensity of concern about the fetus. The EPDS is a set of 10 screening items that can indicate whether a parent has symptoms that are common in women with depression and anxiety during pregnancy and in the year following the birth of a child. The total score is calculated by adding the numbers selected for each of the 10 items, with a cut-off score of 10 points. The validated Spanish version of those instruments were applied during the third trimester. The statistical analysis was performed using the Pearson´s correlation test. Data included descriptive statistics. A p-value < 0.05 was statistically significant. The data were evaluated using the IBM SPSS v24 statistical package (IBM, Armonk, USA).

Results: A total of 23 pregnant women were recruited. A mean age of 27.6 years. The most common diagnosis was rheumatoid arthritis with 10(43.47), followed by antiphospholipid syndrome 5(21.73) and systemic lupus erythematosus 4(17.3), and other diagnosis (fibromyalgia (2), dermatomyositis (1) and Sjogren’s syndrome (1)). The STAI mean score was 133.82 points, the MAAS mean score was 43.82 points, and the EPDS mean score was 7.65 points. A negative moderate correlation was found between MAAS and EPDS (-.605, p=0.002) and also a positive moderate correlation between STAI and EPDS (0.442, p=0.034).

Conclusion: The maternal antenatal attachment had a moderate negative correlation with postnatal depression, meaning the less attachment equals a higher frequency of depressive symptoms. Moreover, a positive correlation between anxiety symptoms and depressive symptoms were found. Strategies to enhance the maternal bond must be addressed during all pregnancy stages. Postpartum women should receive psychological support and be screened for depression and anxiety, especially women with preexisting conditions such as ARDs and other chronic diseases.


Disclosures: L. Espinosa-Banuelos, None; D. Rubio Torres, None; M. Corral, None; C. Skinner Taylor, None; L. Perez-Barbosa, None; L. Gutierrez Leal, None; A. Lujano-Negrete, None; J. Cardenas-de La Garza, None; D. Galarza-Delgado, None.

To cite this abstract in AMA style:

Espinosa-Banuelos L, Rubio Torres D, Corral M, Skinner Taylor C, Perez-Barbosa L, Gutierrez Leal L, Lujano-Negrete A, Cardenas-de La Garza J, Galarza-Delgado D. Maternal Attachment, Anxiety and Depressive Symptoms in Pregnant Women with Rheumatic Diseases [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/maternal-attachment-anxiety-and-depressive-symptoms-in-pregnant-women-with-rheumatic-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/maternal-attachment-anxiety-and-depressive-symptoms-in-pregnant-women-with-rheumatic-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology